Presales Surge Masks Profit Stall—Margin Recovery Unproven
Revenue jumped 40.7% YoY and presales soared 129%, yet net profit fell 18.6%. Management raised guidance mid-cycle while delivering below it. The quarter hinges on one question: can JDA expansion recover margins, or is debt-funded growth obscuring profitability weakness?
₹700 Cr
+129% YoY vs ₹306 Cr Q1 FY26
₹527 Cr
+40.7% YoY, exceeds 20% FY27 guidance
₹70 Cr
+70% YoY, margin 13%
₹13.4 Cr
−18.6% YoY
17-19%
raised from 16-18%; Q1 delivered 13%
₹47 Cr
FY27 target ₹100-120 Cr
On the surface, this is a growth story: presales up 129%, revenue up 40.7%, EBITDA up 70%. But there is a chasm between the headline and the earnings. Net profit fell 18.6% in a quarter where gross profit doubled. The culprit is brutal: interest cost. Management burnt ₹47 crore in Q1 alone — a run-rate that would consume nearly half of the full-year EBITDA guidance. That gap — between a presales surge and a profit stall — is the quarter.
What the numbers say
Start with EBITDA: ₹70 crore, up 70% YoY. That's real. The margin, 13%, is healthy for early-stage project ramp. But subtract the interest burden — ₹47 crore in Q1 — and you're left with ₹23 crore in profit before tax and other items. Add taxes and you get ₹13.4 crore net profit. The math is inescapable: revenue growth is being captured at the EBITDA line, but rising debt service is vaporizing it at net profit. This is the signature of a growth story funded by leverage, not organic cash generation.
Presales ₹700 Cr, 129% YoY growth
₹700 Cr vs ₹306 Cr Q1 FY26; growth confirmed
Supported
Revenue ₹536 Cr, 37% YoY growth
₹527 Cr delivered, +40.7% YoY
Supported (beat by 3.7pp)
EBITDA ₹70 Cr, 70% YoY, margin 13%
₹70 Cr EBITDA (+70% YoY) confirmed; margin 13% vs 11% prior
Supported
FY27 EBITDA margin 17-19% (raised from 16-18%)
Q1 delivered 13%; 400-600 bps gap to guidance
Overstated
PAT growth will follow EBITDA + revenue momentum
Revenue +40.7% but PAT −18.6% YoY; interest ₹47 Cr eroded profit
Contradicted
Net debt-to-equity 0.7x, financial discipline maintained
0.7x confirmed; below 1.0x internal target
Supported
What changed on this call
Guidance raised mid-cycle. EBITDA margin guidance was lifted from 16-18% to 17-19%, yet Q1 delivered only 13%. Management attributed the gap to early-stage JDA project costs; claims recovery will follow in Q2-Q4 as construction crosses revenue-recognition thresholds. This is credibility-dependent: if Q2 margin stays at 13-14%, the full-year guidance is at risk.
JDA presales now 64% of the mix. Of ₹700 Cr Q1 presales, ₹448 Cr (64%) came from 8 JDA projects; owned land (Thane) contributed ₹252 Cr (36%). This is a strategic shift toward a capital-efficient model — 10-15% land deposit vs. 25%+ upfront for owned land acquisitions. It reduces dilution risk but increases execution dependency on partner cooperation.
Debt surged 189% YoY. Gross debt jumped from ₹380 Cr (Q1 FY26) to ₹1,095 Cr (Q1 FY27), funding JDA expansion and Parel acquisition (₹8.5k Cr GDV). Management expects debt to remain elevated for another 1-2 years before moderating as projects mature. This explains the interest cost trajectory: ₹47 Cr Q1 → ₹100-120 Cr FY27 expected.
PAT guidance withdrawn. Unlike prior calls, management refused to quantify FY27 net profit guidance. When pressed, the MD deflected: 'All this money is going towards growth. Once we reach steady state, the debt level will also start to moderate.' Translation: profit visibility is poor amid cost/interest headwinds. This is a red flag for holders accustomed to earnings-per-share clarity.
Institutional investor exodus continues. FII holdings fell from 15.52% (Q1 FY26) to 5.85% (Q1 FY27); DII from 6.35% to 2.89%. Management blamed post-demerger size constraints (FII/DII have minimum market-cap thresholds). Retail and family offices filled the gap. This limits capital-raise flexibility and equity-dilution hedges, forcing continued reliance on debt.
The street's view
The market has a clear opinion. The stock announced the result on August 7 at ₹690 pre-result. By day 1, it had fallen 12%; by day 3, −15.81%; by day 5, −15.67%. The move was decisive and sticky — no rebound. The selloff wasn't a momentary shock; it was a repricing of the profit risk.
Price action confirms the fundamental concern: presales alone don't justify the valuation if profit is stalled. At ₹577.8 today, the stock is down 21.38% from its all-time high and has fallen below both the 20-day and 50-day moving averages. The RSI of 28.9 is technically oversold — a sign of capitulation selling. Yet volume has been increasing, suggesting institutional and HNI exits are structural, not panic.
Bulk/block trades show some institutional buying near ₹630-636 (NK Securities, Junomoneta, DIPAN Mehta Commodities), but dominant selling from brokerages (QE Securities, IRAGE) at similar levels. The net flow is ambiguous — no clear conviction in either direction among large players. This is a market waiting for direction.
Presales +129% YoY; demand validated in Mumbai premium segment
Revenue +40.7% YoY; collection momentum ₹550 Cr (+47% YoY) strong
₹52k Cr GDV pipeline, 7-8 year visibility, capital-efficient JDA model (64% of presales)
Net debt-to-equity 0.7x; financial discipline vs 1.0x target
New IR head (Sumeet Sabharwal) hired; institutional outreach ongoing
PAT fell 18.6% YoY despite revenue +40.7%; profit lagging growth
Interest cost ₹47 Cr Q1 is 67% of EBITDA; FY27 ₹100-120 Cr will consume 33-40% of EBITDA
EBITDA margin 13% vs 17-19% guidance; 400-600 bps gap unproven
PAT guidance withdrawn; management refuses to quantify profit path
Gross debt ₹1,095 Cr (+189% YoY); elevated for next 1-2 years
FII/DII holdings fell 22% → 8% over 4 quarters; institutional confidence eroding
Stock down 21.38% from ATH, RSI 28.9 oversold; market repriced profit risk
Profitability stalled by interest burden
HighRevenue +40.7% but PAT −18.6%. Interest ₹47 Cr Q1 (₹100-120 Cr FY27) consumes 33-40% of EBITDA guidance. If EBITDA misses or debt rises further, profit will sink. Management's silence on PAT is ominous.
EBITDA margin recovery unproven
HighQ1 delivered 13% vs 17-19% FY27 target (400-600 bps gap). Management claims early-stage project costs suppress margins; recovery expected Q2-Q4. If Q2 margins stay 12-14%, full-year guidance is missed and credibility erodes further.
Debt trajectory unsustainable near-term
HighGross debt ₹1,095 Cr (+189% YoY), expected to stay elevated 1-2 more years. If presales slow, collection falters, or interest rates rise, debt-service pressure will spike. D/E 0.7x is healthy but trajectory is steep.
Institutional investor exodus limits capital flexibility
MediumFII+DII fell 22% → 8% over 4 quarters. Limits equity-raise capacity; forces continued debt reliance. If a major shortfall emerges, limited institutional buyers = higher dilution or forced asset sales.
Project execution delays (Mahim Q3-Q4, Parel 18 months)
MediumMonsoon season complicates Q3 launches; approvals still pending for Parel. If Mahim launches slip to Q4 or Parel timeline extends, H2 FY27 presales/revenue will disappoint.
Margin guidance raised while delivering below target
MediumManagement raised EBITDA guidance mid-cycle (16-18% → 17-19%) despite Q1 missing. If this pattern repeats, market will stop believing guidance and re-rate the stock lower.
1 · Q2 EBITDA margin trajectory
Is 13% a trough or a floor? If Q2 margin improves to 14-15%+, the path to 17-19% FY27 guidance becomes credible. If it stays 12-14%, full-year guidance is at risk and profit growth remains stalled. This is the quarter's lynchpin.
2 · Collections & cash conversion
Q1 collections ₹550 Cr (+47% YoY) are strong, but debt is rising faster. Monitor cash realization from presales. If collections momentum falters (< 40% YoY growth in H2), then presales-to-revenue visibility weakens and debt-service pressure rises.
3 · Mahim launches (Q3-Q4) execution
Mahim-1 (₹2,500 Cr GDV) targeted for Nov-Dec 2026 (Q3); Mahim-2 (₹2,100+ Cr) for Q4. Monsoon season risk is acknowledged but minor per management. Monitor approval/construction progress. Any slip to next quarter compresses FY27 presales and defers margin recovery.
4 · Interest cost & debt growth rate
Q1 interest ₹47 Cr annualizes to ~₹188 Cr, yet management guided ₹100-120 Cr FY27. If absolute debt continues rising > 5% per quarter, annual interest could exceed guidance and profit will disappoint further. Track Q2-Q3 absolute debt levels.
5 · Institutional investor sentiment & re-entry
New IR head hired (Sumeet Sabharwal); market-cap growth to ₹4k+ Cr may unlock FII/DII re-entry (size-limit thresholds). Monitor bulk/block trading for institutional buying. If FII/DII re-accumulate, stock will stabilize; continued exodus signals loss of confidence.
This is a steady, capital-efficient growth story — JDA model is sound, presales momentum is real, pipeline is massive. But execution risk is high: margin recovery unproven, profit lagging despite revenue growth, interest burden rising, guidance raised mid-cycle while missing. The market's 15-21% drawdown is justified. At ₹577, the stock is technically oversold (RSI 28.9) and below key moving averages — a potential tactical bounce if Q2 EBITDA margins surprise to the upside. But the fundamental concern (profit stalled by debt service) is real, not transient.
For holders: this is a hold-and-wait quarter. Credibility hinges on Q2 margin recovery and Q3-Q4 project execution. For new buyers: wait for either a Q2 EBITDA beat or further price weakness to ₹520-540 (a 15-20% additional discount) to add at better risk-reward.
The number to track from here: Q2 EBITDA margin. If it's 14%+, the recovery narrative holds. If it's 12-13%, presales momentum was real, but profitability risk persists and the stock will re-test lows.
Raymond Realty: consolidated PAT falls 19% YoY as finance costs surge, revenue up 38%
PAT -18.61% YoY · revenue +38.42% · margins compressing
₹526.67 Cr
+38.42% YoY
₹13.43 Cr
-18.61% YoY
2.51%
-1.7pp YoY
₹2.02
Raymond Realty's consolidated bottom line moved opposite to its headline growth story in Q1 FY27: PAT fell 18.6% YoY to ₹13.4 Cr (from ₹16.5 Cr) even as revenue from operations grew 38.4% YoY to ₹526.7 Cr (total income ₹535.7 Cr, +36.7% YoY, which the company rounds to ₹536 Cr/+37%). Standalone tells a different story again — parent-only revenue actually fell 23% YoY to ₹239.9 Cr while PAT was roughly flat (₹26.4 Cr vs ₹26.9 Cr) — underlining that the consolidated growth is being driven by subsidiary-level (Ten X SPV) projects, not the parent entity; readers comparing the two numbers should note this is a real divergence, not a data error.
Q1 FY-2027 vs prior quarters
The gap between strong revenue/EBITDA growth and a weaker net line sits squarely on finance costs, which more than tripled YoY (₹14.6 Cr to ₹47.2 Cr) as the company draws down debt to fund construction across its JDA and Thane land-parcel pipeline; net debt stood at ₹824 Cr against a 0.7x debt/equity ratio (below its 1.0x ceiling) with cost of debt near 9.6%. Company-defined EBITDA rose 70% YoY to ₹70 Cr with margin expanding to 13% from 11%, but that is still below the 17-19% EBITDA margin range guided for FY27; management calls the shortfall 'expected seasonality' tied to project phase and launch timing, and says margins will normalize as construction crosses revenue-recognition thresholds. Net profit margin, in contrast, compressed to 2.5% from 4.2% a year ago and 13.7% in the immediately preceding (Q4 FY26) quarter — QoQ revenue and PAT both fell sharply (-54% and -92% respectively), consistent with the lumpy, completion-linked revenue recognition typical of real estate rather than a demand problem.
The stock went into the print at ₹690, down 1.4% over the past month of trading.
Management guides for a minimum 20% growth in both pre-sales and revenue for FY27, expecting to outperform this target. Blended EBITDA margins are projected to be between 16% to 18% for FY27, with a clear path for improvement in FY28 as recent project launches mature. The company will continue its strategic focus on as
— This quarter: beat
On management's own FY27 guidance of a minimum 20% growth in pre-sales and revenue, this quarter was a clear beat: booking value surged 129% YoY to ₹700 Cr and customer collections rose 47% YoY to ₹550 Cr, both well ahead of the guided floor, and consolidated revenue growth of 38% is nearly double the guided minimum. We found no specific analyst/brokerage consensus estimate for this quarter's PAT or revenue in public previews, so vsStreet is recorded as unknown rather than guessed. Management's press release frames the quarter as 'healthy' with 'robust momentum,' a framing borne out at the topline and EBITDA level but not at the PAT line once financing costs are included.
W1
EBITDA margin path toward the FY27 guided 17-19% range — printed 13% this quarter; management expects normalization over subsequent quarters as projects cross revenue-recognition thresholds
W2
Finance cost run-rate (₹47.2 Cr in Q1, net debt ₹824 Cr, cost of debt ~9.6%) — watch whether it keeps outpacing EBITDA growth and pressuring consolidated PAT
W3
Conversion of the ₹700 Cr Q1 booking value and the new Parel (~₹8,500 Cr) and Kandivali (~₹3,000 Cr) JDA signings into revenue recognition and collections in coming quarters
Presales surge masks profit pressure; margin recovery key test
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Volume targets hit/beaten (presales +129%, revenue +40.7%), guidance reaffirmed (20% growth, 17-19% EBITDA). But Q1 PAT fell 18.6% YoY; margin guidance raised (16-18% → 17-19%) yet Q1 delivered only 13%.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong presales (+129%) and revenue growth (+40.7%) validate JDA strategy and market demand. But PAT fell 18.6% YoY despite revenue growth; Q1 margin (13%) lags FY27 guidance (17-19%), and rising interest cost (₹47 Cr Q1) dilutes profit. Long-term pipeline (₹52k Cr GDV, 7-8 yr visibility) and capital-efficient model merit optimism, but near-term profitability recovery unproven.
₹526.7 Cr
Revenue · +40.7% YoY₹13.4 Cr
Reported PAT · −18.6% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Booking value INR700 Cr, 129% YoY growth
METPresales INR700 Cr vs INR306 Cr prior Q1; 129% growth confirmed
Revenue INR536 Cr, 37% YoY growth
METDelivered revenue 526.7 Cr, 40.7% YoY growth; call figure close
EBITDA INR70 Cr, 70% YoY, margin 13% vs 11%
METEBITDA growth 70%, margin expansion to 13% confirmed by delivered OPM 11.6%
FY27 EBITDA margin guidance 17-19%
OVERSTATEDQ1 margin 13%, well below FY27 target; raised from prior 16-18% band
PAT growth will follow EBITDA + revenue momentum
MISSRevenue +40.7% but PAT -18.6% YoY; interest cost INR47 Cr Q1 eroded profitability
Net debt 0.7x debt-to-equity, financial discipline maintained
METConfirmed 0.7x, below 1.0x target; liquidity INR271 Cr adequate
Earnings quality
What changed since the last call
EBITDA margin guidance raised
Upgrade16-18% (prior) → 17-19% (now). Call reaffirmed commitment; Q1 delivered 13% but blamed early-stage project costs, claimed recovery in Q2+.
Presales mix shifted to JDA
Upgrade64% of Q1 presales from 8 JDA projects (vs owned land 36%). Capital-efficient model now dominant; de-risks land-buy risk.
Debt increased sharply
DowngradeGross debt ₹1,095 Cr (Q1 FY27) vs ₹380 Cr (Q1 FY26); 189% increase. Funds JDA/project expansion. Interest cost INR47 Cr Q1 expected to reach ₹100-120 Cr full year; profit pressure.
Net profit guidance withdrawn
WithdrawnManagement refused to quantify FY27 PAT guidance; only EBITDA + revenue guided. Signals uncertainty on profit delivery amid cost/interest headwinds; previously implied profit growth from prior calls.
Institutional investor base eroding
DowngradeFII+DII holdings ↓ from 22% (Q1 FY26) to 8% (Q1 FY27). Management blamed post-demerger size limits; retail/family offices filled gap. Limits capital-raising flexibility.
The Q&A
Analysts pressed hard on interest cost burden, PAT guidance absence, and margin recovery timeline. Management held firm on EBITDA guidance and ROCE 20%+ but deflected specifics on net profit, citing growth phase and capex-as-investment logic. Tone defensive but not evasive; acknowledged DII concerns, hired new IR head. Few analysts challenged order book or demand; most accept execution capability.
Execution priorities & demand — Sucrit D Patil, Eyesight Fintrade
AnsweredFocus on Q4 project execution; demand robust, market conditions favorable, no significant demand shift seen. Cost pressures (global) temporary. Govt stable, pro-growth. Plenty of buffers in cost estimates over 5-6 yr project cycles.
Capital allocation — Sucrit D Patil, Eyesight Fintrade
AnsweredD/E 0.7x, well below 1.0x internal target. AIFs exploring SPV-level involvement. Equity last resort. Cost of debt down to 9.6%, rating strong, cash-flow focus with manufacturing mindset. No near-term leverage risk.
Parel project details — Ishita Lodha, Svan Investments
PartialLaunch ~18 months out (Jan 2028). Ticket size ₹6-20 Cr (Address/Invictus, not TenX). 1.7M sqft, ₹8.5k Cr GDV. Pricing/inventory TBD at launch.
Mahim launches — Ishita Lodha, Svan Investments
AnsweredOn track for 2 launches in FY27: Mahim-1 Q3 (Nov-Dec 2026), Mahim-2 Q4 (Feb-Mar 2027). Approvals on track. Monsoon delays minor.
TenX Mahalakshmi SPV — Bhavin Modi, Anand Rathi
DodgedSPV incorporation for pipeline deals. No announcement yet. Multiple SPVs kept ready for projects. Wait for deal signed announcement.
Launch calendar & GDV pipeline — Bhavin Modi, Anand Rathi
Answered2 projects this year: Mahim-1 (₹2.5k Cr GDV), Mahim-2 (₹2.1k Cr). 6 JDAs total launched by FY27 end (out of 8). Remaining 2 (Parel, Kandivali) recent, approvals pending.
JDA model ROE & leverage — Bhavin Modi, Anand Rathi
AnsweredJDA: 10-15% upfront land deposit, bulk to approvals/construction. Capital ₹300-350 Cr per ₹2k Cr GDV deal. Owned land 25-26% margin; JDA 20% target (early stage, scales in FY28+). ROCE >20% due to capital efficiency; blended 17-19% EBITDA FY27.
Interest cost trajectory — Deepak Poddar, Sapphire Capital
AnsweredCost of debt 9.6% stable. Absolute interest Q1 ₹47 Cr; full year ₹100-120 Cr expected (with gross debt ₹1,095 Cr). Debt will grow for another 1-2 years due to expansion, then moderate as projects mature.
Geographic diversification — Prateek, Motilal Oswal
AnsweredFocused on MMR for foreseeable future. Pune studied for 2 years; no deals met return hurdles. Competitor influx into Maharashtra; no need to exit home turf.
JDA control & execution risk — Prateek, Motilal Oswal
Answered100% development control mandatory. Partners become passive. Step-in rights on rehab/approvals if partner delays. Protects brand promise & execution risk.
Finance cost components — Preet Shah, Blue Star Capital
PartialGross debt ₹1,095 Cr, 9.6% cost of debt → ~₹100 Cr base estimate + dues-to-govt interest (8-9%, lower than bank loans). Full-year target ₹100-120 Cr; no exact disclosure yet.
Demand environment — Maanvardhan Baid, Sammaan India PMS
AnsweredDemand remains strong. Home Fest annual event (3 years running), monsoon footfall driver, not distress. Q1 exceeded projections. No softness observed in any project.
Net profit & cash profit guidance — Pushpendu, Individual Investor
DodgedNo PAT guidance given. EBITDA & revenue guided (20%+ growth, 17-19% margin). Growth needs debt (lower cost than equity dilution). Math: EBITDA +20%, interest ₹100-120 Cr → PAT calculation deferred. Shareholder to do math themselves.
FII/DII exodus — Pushpendu, Individual Investor
PartialPost-demerger, size constraints forced DII exits (not performance). Family offices & retail filled gap. Market cap ₹3k→₹4k+ Cr; renewed interest emerging. New IR head (Sumeet Sabharwal) hired for dedicated outreach to institutions. Addressing concern.
Dues-to-govt interest — Akshay Jawahar, Individual Investor
PartialDues-to-govt = govt installments on approval costs. Cost 8-9%, lower than bank rates. Attracts because keeps ROCE high. Full composition disclosure promised, not yet in hand.
Guidance
FY27 minimum 20% YoY revenue growth
HighQ1 delivered +40.7% YoY; 2x guidance minimum already. ₹52k Cr GDV pipeline provides 7-8 yr visibility. Management very confident reaffirmed.
FY27 EBITDA margin 17-19% (raised from prior 16-18%)
MediumQ1 delivered 13%; 400-600 bps below target. Management claims early-stage project upfront costs compress margins; recovery expected Q2-Q4 as projects mature and construction crosses revenue thresholds.
Blended margins owned land 25-26%, JDA 20% at maturity
MediumJDA projects currently below 20% (early stage, price ramp-up expected). By FY28, expected to hit 20%. Thane land already mature at 25-26%. Portfolio-blended 17-19% feasible if mix normalizes.
Capital per JDA ₹300-350 Cr for ₹2k+ Cr GDV projects
HighParel (₹8.5k Cr) peak capital ₹350-500 Cr (phased launch). Asset-light model (10-15% land deposit) vs land-buy (thousands of Cr upfront). Capital-efficient.
Risks the call surfaced
Profitability compression
HighRevenue +40.7% but PAT −18.6% YoY. Interest cost ₹47 Cr Q1, FY27 target ₹100-120 Cr. JDA projects at launch phase have suppressed margins; recovery unproven. Management lacks PAT guidance—signals uncertainty.
Debt sustainability
MediumDebt jumped ₹380 Cr (FY26 Q1) → ₹1,095 Cr (FY27 Q1). Management expects 1-2 more years of elevated debt. D/E 0.7x is healthy but trajectory high. If presales/collections slow, debt service pressure rises.
Execution risk on new projects
MediumParel launch ~18 months (Jan 2028), Mahim-1 Q3 (monsoon season), Mahim-2 Q4. Delays would compress FY27/28 presales and push margin recovery. Monsoon already cited as minor concern.
Institutional investor confidence
MediumFII/DII exited due to post-demerger size constraints (not performance). Retail/family offices filled gap. If major capital raise needed (for JDA funding), limited institutional demand could dilute equity valuation.
Margin recovery timing uncertainty
Medium400-600 bps gap between Q1 margin and full-year target. Management blames early-stage projects; expects normalization in Q2+ as construction crosses revenue thresholds. No detailed bridge provided; risk of shortfall if project costs remain sticky.
Management
Score 6/10. Clear on strategy (JDA model, pipeline), financial discipline (D/E <1x), and execution updates. Evasive on net profit guidance and PAT deceleration risk. Deflects shareholder pressure on institutional exodus with size-limit excuse rather than governance transparency. Volume targets consistently hit or beaten (presales +129%, revenue +40.7%). Margin guidance raised mid-year (16-18% → 17-19%) yet Q1 delivered only 13%; recovery unproven. Project launches (Mahim, Parel) on track but timeline risks acknowledged (monsoon, approvals).
1 · Q2 FY27 (Jul-Sep 2026)
Project construction milestones cross revenue recognition thresholds; margin recovery trajectory visibility
2 · Q3 FY27 (Oct-Dec 2026)
First Mahim project launch (≈₹2,500 Cr GDV); increased presales velocity and profitability ramp
3 · Q4 FY27 (Jan-Mar 2027)
Second Mahim launch (≈₹2,100 Cr GDV) + mature project cash flows; FY27 guidance validation
Long-term pipeline (₹52k Cr GDV, 7-8 yr visibility) and capital-efficient model merit optimism, but near-term profitability recovery unproven.